Colombia To Make HIV Treatment More Accessible Through Compulsory Licensing

Colombia To Make HIV Treatment More Accessible Through Compulsory Licensing

Eurasia Review

Published

After years of mobilization and advocacy, Dolutegravir—a first-line drug in HIV treatment—will be more widely available in Colombia, thanks to a compulsory license issued by the government at the end of April. A compulsory license is when a government allows the production, selling, or import of a patented medicine without...

Full Article